Home › Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis › New York
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis clinical trials in New York
3 studies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis are looking for participants at sites in New York.
Cities in New York
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
- New York Nephrology Vasculitis and Glomerular Center, Albany
- Northwell Health, Great Neck
- Hospital For Special Surgery, New York
RecruitingPhase 4
Ages 18 to 100 · All sexes · Updated Sep 30, 2026 · NCT06072482A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, New York
- Nkarta Investigational Site, Stony Brook
- Nkarta Investigational Site, Syracuse
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Montefiore Medical Center, New York
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.